Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

The FDA has approved Lenacapavir a drug touted to be 999 effective in preventing HIV But it remains inaccessible for Indians ...

National Aids Commission (NAC) and health campaigners have welcomed the approval of a twice-a-year HIV prevention injection ...

The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.

While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.

As Congress finalizes a sweeping new federal spending bill, healthcare providers are sounding the alarm over what could be at ...

Whereas the new HIV prevention drug, Lenacapavir, is a positive step towards HIV prevention, its cost is prohibitive. The simple implication of this is that we need to stick to the tried and tested ...

The FDA recently approved Gilead’s drug, lenacapavir, a powerful HIV prevention drug that only requires two shots a year. The O’Neill Institute for National and Global Health Law issued the ...

A recent study revealed that weed is linked with a doubled mortality risk from cardiac diseases. The study further discovered ...

The 'sitting-rising test' is a non-aerobic fitness assessment of the muscle strength, flexibility, balance, and body composition of an individual ...